Similar articles for PMID: 28546337

Year	Number of Results
2002	1
2003	2
2004	1
2005	1
2006	2
2007	1
2008	2
2009	3
2010	5
2011	5
2012	8
2013	10
2014	8
2015	8
2016	16
2017	14
2018	14
2019	24
2020	17
2021	21
2022	19
2023	7
2024	0

1

PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor.

Jacobson O, Li Q, Chen H, Niu G, Kiesewetter DO, Xu L, Cook K, Yang G, Dall'Acqua W, Tsui P, Peng L, Chen X. Jacobson O, et al. J Nucl Med. 2017 Nov;58(11):1838-1844. doi: 10.2967/jnumed.117.192245. Epub 2017 May 25. J Nucl Med. 2017. PMID: 28546337 Free PMC article.

2

Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.

Azhdarinia A, Voss J, Ghosh SC, Simien JA, Hernandez Vargas S, Cui J, Yu WA, Liu Q, Carmon KS. Azhdarinia A, et al. Mol Pharm. 2018 Jun 4;15(6):2448-2454. doi: 10.1021/acs.molpharmaceut.8b00275. Epub 2018 May 8. Mol Pharm. 2018. PMID: 29718672

3

Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice.

Cai W, Ebrahimnejad A, Chen K, Cao Q, Li ZB, Tice DA, Chen X. Cai W, et al. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2024-36. doi: 10.1007/s00259-007-0503-5. Epub 2007 Aug 3. Eur J Nucl Med Mol Imaging. 2007. PMID: 17673999

4

Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.

Burvenich IJ, Parakh S, Gan HK, Lee FT, Guo N, Rigopoulos A, Lee ST, Gong S, O'Keefe GJ, Tochon-Danguy H, Kotsuma M, Hasegawa J, Senaldi G, Scott AM. Burvenich IJ, et al. J Nucl Med. 2016 Jun;57(6):974-80. doi: 10.2967/jnumed.115.169839. Epub 2016 Mar 3. J Nucl Med. 2016. PMID: 26940768 Free article.

5

ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1.

Williams SP, Ogasawara A, Tinianow JN, Flores JE, Kan D, Lau J, Go M, Vanderbilt AN, Gill HS, Miao L, Goldsmith J, Rubinfeld B, Mao W, Firestein R, Yu SF, Marik J, Terwisscha van Scheltinga AG. Williams SP, et al. Oncotarget. 2016 May 3;7(18):25103-12. doi: 10.18632/oncotarget.8390. Oncotarget. 2016. PMID: 27029064 Free PMC article.

6

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D, Senter PD, Gao C, Wu H, Kinch M, Coats S, Kiener PA, Tice DA. Jackson D, et al. Cancer Res. 2008 Nov 15;68(22):9367-74. doi: 10.1158/0008-5472.CAN-08-1933. Cancer Res. 2008. PMID: 19010911

7

Manipulation of Cell-Type Selective Antibody Internalization by a Guide-Effector Bispecific Design.

Lee NK, Su Y, Bidlingmaier S, Liu B. Lee NK, et al. Mol Cancer Ther. 2019 Jun;18(6):1092-1103. doi: 10.1158/1535-7163.MCT-18-1313. Epub 2019 Apr 8. Mol Cancer Ther. 2019. PMID: 30962321 Free PMC article.

8

Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.

Hall MA, Pinkston KL, Wilganowski N, Robinson H, Ghosh P, Azhdarinia A, Vazquez-Arreguin K, Kolonin AM, Harvey BR, Sevick-Muraca EM. Hall MA, et al. J Nucl Med. 2012 Sep;53(9):1427-37. doi: 10.2967/jnumed.112.106302. Epub 2012 Aug 7. J Nucl Med. 2012. PMID: 22872743 Free article.

9

EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.

Lee JW, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK. Lee JW, et al. J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205. doi: 10.1093/jnci/djp231. Epub 2009 Jul 29. J Natl Cancer Inst. 2009. PMID: 19641174 Free PMC article.

10

In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab.

Roy J, Jagoda EM, Basuli F, Vasalatiy O, Phelps TE, Wong K, Ton AT, Hagemann UB, Cuthbertson AS, Cole PE, Hassan R, Choyke PL, Lin FI. Roy J, et al. Cancer Biother Radiopharm. 2021 May;36(4):316-325. doi: 10.1089/cbr.2020.4492. Cancer Biother Radiopharm. 2021. PMID: 34014767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year